IRIS
ORANGER, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.138
AS - Asia 2.773
EU - Europa 2.598
SA - Sud America 739
AF - Africa 238
Continente sconosciuto - Info sul continente non disponibili 231
OC - Oceania 9
Totale 12.726
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.007
SG - Singapore 1.162
IT - Italia 964
CN - Cina 652
BR - Brasile 562
SE - Svezia 346
HK - Hong Kong 298
RU - Federazione Russa 259
DE - Germania 248
VN - Vietnam 198
FI - Finlandia 171
UA - Ucraina 168
FR - Francia 145
CI - Costa d'Avorio 140
GB - Regno Unito 121
IN - India 88
BD - Bangladesh 72
CA - Canada 66
AR - Argentina 63
ID - Indonesia 47
NL - Olanda 35
MX - Messico 34
TR - Turchia 32
CO - Colombia 31
IQ - Iraq 31
PL - Polonia 29
JP - Giappone 26
SA - Arabia Saudita 26
PK - Pakistan 25
ZA - Sudafrica 25
IE - Irlanda 24
VE - Venezuela 22
EC - Ecuador 19
MA - Marocco 17
ES - Italia 16
PY - Paraguay 15
LT - Lituania 14
PH - Filippine 14
CL - Cile 11
TN - Tunisia 11
AT - Austria 10
ET - Etiopia 10
IR - Iran 10
LB - Libano 10
UZ - Uzbekistan 10
BE - Belgio 9
JM - Giamaica 9
MY - Malesia 9
PE - Perù 9
AU - Australia 8
EG - Egitto 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
IL - Israele 7
AZ - Azerbaigian 6
HN - Honduras 6
KE - Kenya 6
KR - Corea 6
JO - Giordania 5
AO - Angola 4
BY - Bielorussia 4
CH - Svizzera 4
NI - Nicaragua 4
SY - Repubblica araba siriana 4
AL - Albania 3
CY - Cipro 3
MU - Mauritius 3
SI - Slovenia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MN - Mongolia 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
EU - Europa 1
GA - Gabon 1
Totale 12.478
Salva come PNG Salva come JPEG
Città #
Singapore 643
Ashburn 552
San Jose 515
Fairfield 414
Chandler 390
Jacksonville 373
Woodbridge 348
Hong Kong 297
Milan 280
Houston 249
Nyköping 247
Bari 222
Cambridge 184
Beijing 174
Ann Arbor 173
Seattle 165
Council Bluffs 152
Dallas 148
Abidjan 140
Wilmington 137
Los Angeles 110
New York 107
Lauterbourg 96
Roxbury 95
Lawrence 92
Nanjing 87
Rome 84
Boardman 72
Munich 69
Helsinki 67
Des Moines 65
Ho Chi Minh City 61
Brooklyn 55
Santa Clara 53
Hanoi 52
São Paulo 50
Buffalo 46
Princeton 42
Inglewood 40
Columbus 39
Dearborn 37
San Diego 34
Shenyang 32
Figino 29
London 29
Jakarta 28
Chicago 26
Nanchang 26
Warsaw 26
Falkenstein 25
Pune 25
Dublin 24
Montreal 23
Phoenix 22
Turin 22
Orem 21
Atlanta 19
Changsha 19
Guangzhou 19
Johannesburg 19
Moscow 18
Tokyo 18
Turku 18
Baghdad 17
Hebei 17
Jiaxing 17
Toronto 16
Denver 15
Noicattaro 15
Rio de Janeiro 15
Tianjin 15
Mexico City 14
Paris 14
San Francisco 14
Trani 14
Frankfurt am Main 13
Manchester 13
Belo Horizonte 12
Redwood City 12
Charlotte 11
Haiphong 11
Caracas 10
Chennai 10
Hefei 10
Jeddah 10
Stockholm 10
Boydton 9
Brussels 9
Naples 9
Orta Nova 9
Riyadh 9
Salt Lake City 9
Salvador 9
Shanghai 9
Tashkent 9
Wuhan 9
Addis Ababa 8
Bogotá 8
Brasília 8
Campinas 8
Totale 8.171
Salva come PNG Salva come JPEG
Nome #
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 242
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α 217
Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: Crosstalk between the immune and bone systems 213
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 195
Aortic valvular interstitial cells apoptosis and calcification is mediated by TNF-related apoptosis-inducing ligand 188
TRAIL effect on osteoclast formation in physiological and pathological conditions 170
Sclerostin stimulates angiogenesis in human endothelial cells 166
Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL 164
Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 162
Cellular mechanisms of multiple myeloma bone disease 159
Alteration of the osteogenic properties of bone marrow stromal cells from multiple myeloma bone disease patients 158
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 156
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 154
Osteogenic differentiation of dental follicle stem cells. 147
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 144
Alteration of bone remodeling in multiple myeloma bone disease: role of sclerostin 143
Irisin Treatment Prevents Isoproterenol-Induced Cardiac Fibrosis in Mice 142
The effect of Irisin on bone cells in vivo and in vitro 141
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 140
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 138
Soluble Decoy Receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 137
THE ROLE OF LIGHT ON BONE REMODELING 136
Altered osteogenic properties of bone marrow stromal cells from multiple myeloma patients 134
Another link between bone and immune system: LIGHT 132
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis 132
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 131
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 129
TRAIL is involved in human osteoclast apoptosis 128
Alterazione del potenziale osteogenico in osteoblasti ottenuti da soggetti affetti da malattia parodontale: ruolo dei recettori apoptotici per TRAIL 127
Osteoblast Apoptosis in Periodontal Disease: Role of TNF-related apoptosis-inducing ligand 127
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 125
Alterazione del rimodellamento osseo in soggetti in età pediatrica affetti da deficit di 21-idrossilasi (21-OHD): ruolo di DKK1 125
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 125
Shedding “LIGHT” on the Link between Bone and Fat in Obese Children and Adolescents 124
Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism 123
Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis. 123
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 123
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 122
Alterazione delle capacità osteogeniche in cellule stromali ottenute da midollo osseo di pazienti affetti da mieloma multiplo 121
Myeloma cells suppress osteoblasts through sclerostin secretion 121
T cells support osteoclastogenesis in an in vitro model derived from psoritic arthritis 120
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 120
LIGHT INVOLVEMENT IN MULTIPLE MYELOMA-OSTEOLYTIC BONE DISEASE 120
Elevati livelli sierici di Dkk1, antagonista del segnale di WNT in bambini obesi. 118
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 118
In vitro osteoclastogenesis and T-cell RANKL expression in multiple myeloma-bone disease at diagnosis and in the setting of frontline treatment 117
The Role of LIGHT in Multiple Myeloma-Bone Disease 117
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 116
Osteoblasts display different responsiveness to TRAIL- induced apoptosis during their differentiation process 114
LIGHT: another link between bone and immune system 113
Irisin and Secondary Osteoporosis in Humans 113
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma 113
DCR3 involvement in multiple myeloma bone disease 110
Failure of an in vitro model of osteoclastogenesis in human plasma cell leukaemia (PCL) 109
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 106
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 106
Mechanism of Bone Disease in Prader-Willi Syndrome 106
Circulating levels of cathepsin-k in multiple myeloma patients 105
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 104
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 103
The role of the Wnt-signaling antagonist Sclerostin in the development of osteolytic lesions in multiple myeloma 103
Bone Cells 102
DcR3 involvement in multiple myeloma bone disease 101
Myeloma cells induce osteoblast suppression through sclerostin secretion 101
High levels of LIGHT/TNFSF14 in patients with Prader–Willi syndrome 99
Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner's Syndrome 97
Dental pulp stem cells: osteogenic differentiation and genes expression 97
Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease 97
LIGHT: a new potential molecule involved in bone loss 96
Sclerostin, produced by myeloma plasma cell, suppresses osteoblast activity 96
No spontaneous osteoclast formation in an in vitro model derived from primary plasma cell leukemia 96
The role of light (TNFSF14) on bone remodeling 95
Impairment of osteoblast diffeentiation and activity through sclerostin in multiple myeloma bone disease ??? 91
Osteoclast apoptosis: Role of TRAIL and its receptors 90
Osteoclast formation in Multiple Myeloma bone disease patients: role of DcR3 89
Detection of the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 89
Spontaneous osteoclastogenesis TNF-a and RANKL mediated in patients with Turner syndrome. 88
Soluble decoy receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 88
TRAIL effect on osteoclast formation in multiple myeloma-bone disease 88
Correlation Between Irisin and Cognitive Functions in Alzheimer Dementia 86
Decoy Receptor 3 DcR3 supports osteoclast formation in multiple myeloma bone disease patients through RANKL and TNF-ALPHA up-regulation 86
High serum levels of the WNT-signaling antagonist Dkk1 in obese children 86
IRISIN AND METASTATIC MELANOMA: SELECTIVE ANTI-INVASIVENESS ACTIVITY IN BRAF WILD-TYPE CELLS 85
Osteogenic properties of human dental pulp stem cells 84
Osteoblast apoptosis in periodontal disease: role of TRAIL 84
Survival and formation of osteoclasts from multiple myeloma bone disease patients: role of decoy receptor 3 (DCR3) 83
High serum levels of the WNT-signaling antagonist Dkk1 in children with 21-hydroxylase deficiency (21-OHD) 80
DcR3 supports osteoclast formation in multiple myeloma bone disease patients through RANKL and TNFα up-regulation 80
Osteoclastogensi spontanea TNF-alpha e RANKL mediata in pazienti con Sindrome di Turner 80
Shedding LIGHT on bone cell differentiation and Multiple Myeloma-bone disease 80
Inflammatory Cells in Diffuse Large B Cell Lymphoma 80
Le cellule T supportano la formazione di osteoclasti in vitro in campioni di sangue periferico ottenuti da pazienti affetti da artrite psoriasica 78
Ridotta attività degli osteoblasti nel mieloma multiplo: ruolo della sclerostina 78
Inhibition of osteoclast apoptosis in multiple myeloma bone diseases: role of DCR3 78
Ruolo di LIGHT (tnfsf14) nella malattia ossea associata al mieloma multiplo 77
The role of the Wnt-signaling antagonist sclerostin in the development of osteolytic lesions in multiple myeloma 77
Evaluation of serum levels of cathepsin k in multiple myeloma patients 76
Formazione e sopravvivenza di osteoclasti in pazienti affetti da mieloma multiplo: ruolo di DcR3 76
Formazione di osteoclasti in un modello in vitro derivato da pazienti affetti da mieloma multiplo: interazione OPG/TRAIL 75
null 74
Totale 11.618
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.101
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022667 0 0 5 32 26 50 28 35 128 40 134 189
2022/20231.144 166 122 64 85 140 134 22 131 228 5 18 29
2023/2024425 45 84 12 27 35 114 8 4 1 27 25 43
2024/20252.061 127 27 141 70 47 201 285 165 70 134 267 527
2025/20264.736 634 213 430 510 504 254 480 188 492 408 129 494
2026/2027579 145 210 224 0 0 0 0 0 0 0 0 0
Totale 12.726